Drug intelligence / Profile preview

saline + ketamine

Development stage
Unknown
Lead developer
NRx Pharmaceuticals
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration
Intravenous, Intramuscular, Intranasal
01

Overview

Saline + ketamine refers to a compounded or admixture formulation in which ketamine, a dissociative anesthetic and N-methyl-D-aspartate (NMDA) receptor antagonist, is combined with saline (sterile sodium chloride solution) for administration. This combination is not a unique branded product but rather describes the practice of diluting or dissolving ketamine in saline for intravenous, intramuscular, or sometimes intranasal use. Ketamine acts primarily by blocking NMDA receptors in the brain, leading to anesthesia, analgesia, and dissociative effects. It is FDA-approved as an anesthetic agent but also used off-label for pain management and treatment-resistant depression. Saline serves as an inert vehicle to deliver the active drug. Compounded formulations such as this are not FDA-approved; their safety and efficacy profiles depend on compounding practices[1][6].

02

Targets

N-methyl-D-aspartate receptor (NMDAR) - Phencyclidine (PCP) binding site

Beyond the preview

Go deeper on saline + ketamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on saline + ketamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call